Company news

Fulgent Genetics, Inc. news in 2023

Fulgent Genetics, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Fulgent to Participate in the Piper Sandler 35th Annual Healthcare Conference

November 13, 2023

Fulgent Shares Data from Two Poster Presentations at SITC 2023 Annual Meeting

November 2, 2023

Fulgent Reports Third Quarter 2023 Financial Results

November 2, 2023

Fulgent Announces Two Poster Presentations at SITC 2023 Annual Meeting

October 24, 2023

Fulgent Genetics to Announce Third Quarter 2023 Financial Results on Friday November 3, 2023

October 16, 2023

Fulgent Reports Second Quarter 2023 Financial Results

August 3, 2023

Fulgent Genetics to Announce Second Quarter 2023 Financial Results on Friday, August 4, 2023

July 17, 2023

Fulgent Data at ASCO 2023 Highlights Progress for Its Lead Therapeutic Oncology Candidate, FID-007, in Various Cancers

June 4, 2023

Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2023 Annual Meeting

May 17, 2023

Fulgent Reports First Quarter 2023 Financial Results

May 4, 2023

Fulgent Genetics to Announce First Quarter 2023 Financial Results on Friday May 5, 2023

April 19, 2023

Fulgent Reports Fourth Quarter and Full Year 2022 Financial Results

February 27, 2023

Fulgent Genetics Launches New Beacon787 Expanded Carrier Screening Panel

February 27, 2023

Fulgent to Participate in the Raymond James & Associates’ 44th Annual Institutional Investors Conference

February 22, 2023

Fulgent Genetics to Announce Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 28, 2023

February 13, 2023

Fulgent Expands Board of Directors with Addition of Reggie Groves

January 2, 2023

Calls in 2023

Decks in 2023